Corrigendum to: Pharmacokinetic-Pharmacodynamic Model of Vedolizumab for Targeting Endoscopic Remission in Patients with Crohn Disease: Posthoc Analysis of the LOVE-CD Study

Detalles Bibliográficos
Autores principales: Hanzel, Jurij, Dreesen, Erwin, Vermeire, Séverine, Löwenberg, Mark, Hoentjen, Frank, Bossuyt, Peter, Clasquin, Esmé, Baert, Filip J, D’Haens, Geert R, Mathôt, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Corrigenda
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071094/
https://www.ncbi.nlm.nih.gov/pubmed/34788812
http://dx.doi.org/10.1093/ibd/izab270

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071094/
https://www.ncbi.nlm.nih.gov/pubmed/34788812
http://dx.doi.org/10.1093/ibd/izab270

Ejemplares similares